S. Schulman et al., THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 75(4), 1996, pp. 607-611
An impaired fibrinolytic function has been described in several case-c
ontrol studies of patients with venous thromboembolism (VTE). In the p
resent study the correlations between some fibrinolytic compounds and
future recurrent VTE were investigated. Blood samples for analysis of
tissue-type plasminogen activator (t-PA) antigen before and after 10 m
in of venous occlusion (V.O.) and plasminogen activator inhibitor type
1 (PAI-1) activity were taken at 6 months after the first episode of
VTE or the first recurrent VTE in 784 and 207 patients, respectively,
who were anticoagulated for 1.5 or 6 months (first VTE) and 6 months o
r indefinitely (first recurrence). During a follow-up of 3-6 years fro
m the event which qualified for inclusion there have been 177 recurren
ces. All initial and recurrent events were verified with objective dia
gnostic methods. Using cut off points of 10.0 ng/ml for t-PA antigen b
efore V.O. and 30 AU/ml for PAI-1 in samples taken at rest, there were
more patients above those level in the groups with than without furth
er recurrence (t-PA antigen, 50% versus 36%, p = 0.001; PAI-1, 18% ver
sus 12%, p = 0.045). In the 495 patients, who received oral anticoagul
ation for 6 months, t-PA antigen at rest discriminated better, with 59
% versus 34% of patients above 10 ng/ml in the groups with and without
recurrence, respectively (p < 0.001). The t-PA antigen levels after V
.O. and the fibrinolytic capacity (t-PA antigen after V.O. minus t-PA
antigen before V.O.) were distributed similarly in patients with and w
ithout new; recurrences. There was a statistically significant positiv
e correlation between age and t-PA antigen (p < 0.001), and by analysi
s of covariance the difference between the groups with and without fur
ther recurrence regarding t-PA antigen disappeared. In conclusion, inc
reased levels of PAI-1 and t-PA antigen in VTE-patients correlate with
development of recurrent VTE within the next 3-6 years, but the value
of these components in predicting future events for the individual pa
tient is limited.